RESUMO
A 32-year old man treated for several years with phenothiazine for chronic psychosis developed acute necrotizing colitis. The causal relationship with neuroleptics was reinforced by the absence of any other treatment and by histological findings including extensive mucosal necrosis without stenotic lesion and without mesenteric vessels alteration. The patient required emergency total colectomy and was discharged after 7 weeks of hospitalisation in the intensive care unit.
Assuntos
Antipsicóticos/efeitos adversos , Enterocolite Pseudomembranosa/induzido quimicamente , Doença Aguda , Adulto , Antipsicóticos/uso terapêutico , Relação Dose-Resposta a Droga , Enterocolite Pseudomembranosa/patologia , Enterocolite Pseudomembranosa/cirurgia , Humanos , Masculino , Fenotiazinas , Transtornos Psicóticos/tratamento farmacológico , Fatores de TempoRESUMO
Prosthetic vascular graft infection is a rare but very severe complication with a high death rate. Its optimal management requires appropriate surgical procedures combined with adequate antimicrobial treatment in reference center. The authors wanted to focus on the management of prosthetic vascular graft infection and define the clinical, microbiological, biological, and radiological criteria of vascular graft infection. Complementary investigations, although these are small series, include CT scan, the gold standard for the diagnosis of acute infection with a sensitivity and specificity reaching 100%, but decreased to 55% in case of chronic infection. More recently, PET-scanning was studied and yielded good results in chronic infections (sensitivity 98%, specificity 75.6%, positive predictive value 88.5%, and negative predictive value 84.4%). Managing prosthetic vascular graft infection, as with the orthopedic and vascular infections, requires replacing the vascular prosthesis. There is no correlation between the microbiological data and the location or type of vascular infection. Thus, the postoperative intravenous antibiotherapy should be bactericidal with a broad-spectrum. After obtaining intra-operative microbiological results, de-escalation therapy must include at least one anti-adherence agent, such as rifampicin in staphylococcal infections.
Assuntos
Infecções Bacterianas/diagnóstico , Infecções Bacterianas/tratamento farmacológico , Prótese Vascular/efeitos adversos , Diagnóstico por Imagem/métodos , Infecções Relacionadas à Prótese/diagnóstico , Infecções Relacionadas à Prótese/tratamento farmacológico , Assistência ao Convalescente , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Aderência Bacteriana/efeitos dos fármacos , Infecções Bacterianas/sangue , Infecções Bacterianas/diagnóstico por imagem , Infecções Bacterianas/cirurgia , Terapia Combinada , Meios de Contraste , Remoção de Dispositivo , Gerenciamento Clínico , Resistência Microbiana a Medicamentos , Humanos , Angiografia por Ressonância Magnética , Tomografia por Emissão de Pósitrons , Valor Preditivo dos Testes , Infecções Relacionadas à Prótese/sangue , Infecções Relacionadas à Prótese/cirurgia , Reoperação , Sensibilidade e Especificidade , Tomografia Computadorizada por Raios X , Ultrassonografia DopplerRESUMO
Prosthetic vascular graft infection (PVGI) is a devastating complication, with a mortality rate of up to 75%, which is especially caused by aortic graft infection. The purpose of this study was to evaluate factors associated with in-hospital mortality of patients with definite graft infection, and with long-term outcome. We reviewed medical records of 85 patients treated for PVGIs defined by positive bacterial culture of intraoperative specimens or blood samples, and/or clinical, biological and radiological signs of infection. In-hospital patient mortality was defined as any death occurring during the initial treatment of the graft infection. Cure was defined as the absence of evidence of relapsing infection during long-term follow-up (≥1 year). Eighty-five patients (54 aortic and 31 limb graft infections) treated by surgical debridement and removal of the infected prosthesis (n=41), surgical debridement without removal of prosthesis (n=34) or antimicrobial treatment without surgery (n=10) were studied. The only microbiological difference observed between patients with early (occurring within 4 months after surgery) vs. late PVGI and between those with aortic vs. limb PVGI was the incidence of PVGI caused by Staphylococcus aureus, which was greater in patients with limb PVGI. Overall cure was observed in 93.2% of 59 patients with a follow-up of a minimum of 1 year. Overall in-hospital mortality was 16.5% (n=14). Two variables were independently associated with mortality: age >70 years (OR 9.1, 95% CI 1.83-45.43, p 0.007) and aortic graft infection (OR 5.6, 95% CI 1.1-28.7, p 0.037).